Canlyniadau Chwilio - Tsai, Max

Paclitaxel-loaded polymeric microparticles: Quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics gan Tsai, Max, Lu, Ze, Wientjes, M. Guillaume, Au, Jessie L.-S.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol gan Tsai, Max, Case, Michael, Ardayfio, Paul, Hochstetler, Helen, Wilbraham, Darren

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor gan Tsai, Max, Chrones, Lambros, Xie, Jinhui, Gevorkyan, Hakop, Macek, Thomas A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis gan Naik, Himanshu, Tsai, Max C., Fiedler-Kelly, Jill, Qiu, Ping, Vakilynejad, Majid

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus gan Dudkowski, Caroline, Tsai, Max, Liu, Jie, Zhao, Zhen, Schmidt, Eric, Xie, Jeannie

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor‐Positive Allosteric Modulator (D1PAM), in Healthy Subjects gan Wilbraham, Darren, Biglan, Kevin M., Svensson, Kjell A., Tsai, Max, Kielbasa, William

Cael y testun llawn Cael y testun llawn Cael y testun llawn

TUMOR PENETRATING MICROPARTICLES FOR INTRAPERITONEAL THERAPY OF OVARIAN CANCER gan Lu, Ze, Tsai, Max, Lu, Dan, Wang, Jie, Wientjes, M. Guillaume, Au, Jessie L.-S.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Single-dose pharmacokinetics and safety of azilsartan medoxomil in children and adolescents with hypertension as compared to healthy adults gan Webb, Nicholas J. A., Wells, Thomas, Tsai, Max, Zhao, Zhen, Juhasz, Attila, Dudkowski, Caroline

Cael y testun llawn Cael y testun llawn Cael y testun llawn

EFFECTS OF CARRIER ON DISPOSITION AND ANTITUMOR ACTIVITY OF INTRAPERITONEAL PACLITAXEL gan Tsai, Max, Lu, Ze, Wang, Jie, Yeh, Teng-Kuang, Wientjes, M. Guillaume, Au, Jessie L.-S.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor–Positive Allosteric Modulator, in Patients With Parkinson Disease gan Wilbraham, Darren, Biglan, Kevin M., Svensson, Kjell A., Tsai, Max, Pugh, Melissa, Ardayfio, Paul, Kielbasa, William

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Multiscale Tumor Spatiokinetic Model for Intraperitoneal Therapy gan Au, Jessie L.-S., Guo, Peng, Gao, Yue, Lu, Ze, Wientjes, Michael G., Tsai, Max, Wientjes, M. Guillaume

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study gan Wilbraham, Darren, Berg, Paul H., Tsai, Max, Liffick, Emily, Loo, Li Shen, Doty, Erin Gautier, Sellers, Edward

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A Randomized Multiple Dose Pharmacokinetic Study of a Novel PDE10A Inhibitor TAK-063 in Subjects with Stable Schizophrenia and Japanese Subjects and Modeling of Exposure Relationsh... gan Goldsmith, Paul, Affinito, John, McCue, Maggie, Tsai, Max, Roepcke, Stefan, Xie, Jinhui, Gertsik, Lev, Macek, Thomas A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls gan Pearlman, Eric M., Wilbraham, Darren, Dennehy, Ellen B., Berg, Paul H., Tsai, Max, Doty, Erin G., Kay, Gary G.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine gan Tsai, Max, Nery, Emel Serap Monkul, Kerr, Lisa, Khanna, Rashna, Komori, Mika, Dennehy, Ellen B., Wilbraham, Darren, Winner, Paul

Cael y testun llawn Cael y testun llawn Cael y testun llawn

An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients gan Gilleen, James, Farah, Yakub, Davison, Cate, Kerins, Sarah, Valdearenas, Lorena, Uz, Tolga, Lahu, Gez, Tsai, Max, Ogrinc, Frank, Reichenberg, Avi, Williams, Steve C., Mehta, Mitul A., Shergill, Sukhi S.

Cael y testun llawn Cael y testun llawn Cael y testun llawn